Studies have found that the silence of keratin 17 (KRT17) results in significantly reduced expression of mesenchymal DNA in cancer cells leading to decreased migratory, invasive abilities, and reversing the resistance to cisplatin (Jang et al., 2022). This evidence concerns the gene KRT17 and cancer.